Dr. Betts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-672-7422
Summary
- Dr. Brian Betts is a hematologist in Minneapolis, MN and is affiliated with University of Minnesota. He received his medical degree from Eastern Virginia Medical School and has been in practice 16 years. He specializes in hematologic oncology and is experienced in graft-versus-host disease, stem cell transplantation, leukemia, and cell therapy.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
University of MinnesotaResidency, Internal Medicine, 2004 - 2007
Eastern Virginia Medical SchoolClass of 2004
Certifications & Licensure
NY State Medical License 2008 - 2025
MN State Medical License 2018 - 2024
FL State Medical License 2011 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 75 citationsRace/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.Joseph Pidala, Jongphil Kim, Michael J. Schell, Stephanie J. Lee, Ryan Hillgruber
Bone Marrow Transplantation. 2013-03-01 - 55 citationsHDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristicsAndressa S. Laino, Brian C. Betts, A. Veerapathran, Igor Dolgalev, Amod A. Sarnaik
Journal for Immunotherapy of Cancer. 2019-02-06 - 19 citationsFacilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factorShernan G. Holtan, Andrea Hoeschen, Qing Cao, Mukta Arora, Veronika Bachanova
Blood Advances. 2020-04-14
Press Mentions
Pacritinib with Sirolimus/Tacrolimus Does Not Prevent Acute GVHDAugust 28th, 2024- VITRAC Therapeutics Initiates a Phase 1/2 Clinical Trial with the Aurora Kinase a Inhibitor VIC-1911 in GVHD ProphylaxisApril 26th, 2022
- Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy ProgramDecember 7th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
